Benzinga's Top Downgrades

Analysts at Citigroup downgraded Actuant

from “buy” to “neutral.” Actuant's shares closed at $25.81 yesterday. Actuant's trailing-twelve-month ROE is 14.43%. Analysts at Goldman downgraded Xylem

from “neutral” to “sell.” Xylem's shares closed at $24.29 yesterday. Xylem's PEG ratio is 2.33. Analysts at Bernstein downgraded Weatherford International Ltd

from “outperform” to “market perform.” Weatherford's shares closed at $12.24 yesterday. Weatherford's trailing-twelve-month profit margin is 2.53%. JMP Securities downgraded Anthera Pharmaceuticals

from “outperform” to “market perform.” Anthera Pharmaceuticals' shares closed at $2.75 yesterday. Anthera Pharmaceuticals' trailing-twelve-month ROA is -92.62%.